Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: Which biological markers of the liver function affect the enhancement?
- 23 October 2009
- journal article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 30 (5), 1042-1046
- https://doi.org/10.1002/jmri.21956
Abstract
Purpose: To clarify the factors that predict enhancement of the liver parenchyma in hepatocyte‐phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd‐EOB‐DTPA)‐enhanced MR imaging. Materials and Methods: Gd‐EOB‐DTPA–enhanced hepatocyte‐phase MR images of 198 patients with chronic liver diseases (Child‐Pugh class A in 112 patients, class B in 74 patients, and class C in 12 patients) were retrospectively analyzed. The hepatocyte‐phase images were obtained using fat‐suppressed T1‐weighted gradient‐echo images with a 3D acquisition sequence 10 min and 20 min after IV administration of Gd‐EOB‐DTPA (0.025 mmol/kg body weight). The quantitative liver–spleen contrast ratio (Q‐LSC) was calculated using the signal intensities of the liver and spleen. Serum albumin levels, total bilirubin levels, prothrombin activity, and the results of indocyanine green clearance tests (ICGs) were recorded and correlated with the Q‐LSC. Logistic regression analysis was performed to analyze which factors predict sufficient liver enhancement using a Q‐LSC of 1.5 as a cutoff value. Results: Only ICGs and Child‐Pugh classifications showed a statistically significant correlation with the Q‐LSC. Logistic regression analysis showed that ICGs were the only factors that accurately predicted liver enhancement on hepatocyte‐phase images. Conclusion: ICGs were found to be predictors of sufficient liver enhancement on hepatocyte‐phase images. J. Magn. Reson. Imaging 2009;30:1042–1046.Keywords
This publication has 17 references indexed in Scilit:
- Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte‐specific contrast‐enhanced MRIJournal of Magnetic Resonance Imaging, 2009
- Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesionsEuropean Radiology, 2008
- Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesionsEuropean Radiology, 2007
- Assessing liver functionCurrent Opinion in Critical Care, 2007
- Liver Tumor CharacterizationJournal of Computer Assisted Tomography, 2006
- Preoperative assessment of liver functionSurgical Clinics of North America, 2004
- Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPAKorean Journal of Radiology, 2004
- Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomyBritish Journal of Surgery, 1997
- Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomyBritish Journal of Surgery, 1997
- The indocyanine green test enables prediction of postoperative complications after hepatic resectionWorld Journal of Surgery, 1987